Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vanadyl sulfate is a compound containing vanadium, a trace mineral that has drawn interest for its potential insulin-mimetic effects. The rationale for its use in supporting or treating Metabolic Syndrome, particularly insulin resistance and type 2 diabetes, is based on research demonstrating that vanadium compounds can enhance insulin sensitivity and glucose uptake in animal models and in some early human studies. Small clinical trials in the 1990s and early 2000s showed that vanadyl sulfate supplementation (typically 50-150 mg/day) improved insulin sensitivity, fasting glucose, and glycemic control in people with type 2 diabetes. However, these studies were short-term, involved small sample sizes, and sometimes lacked placebo controls. The proposed mechanism of action involves vanadyl sulfate's ability to modulate insulin receptor signaling and promote glucose uptake in peripheral tissues.

Despite these findings, the overall quality and consistency of the evidence are low. More recent and larger controlled studies have not been conducted, and concerns about the potential toxicity of vanadium at higher doses have limited enthusiasm for its widespread use. Most expert guidelines do not recommend vanadyl sulfate for Metabolic Syndrome due to insufficient evidence of long-term efficacy and safety. In summary, while there is some scientific basis for vanadyl sulfate's potential benefits in Metabolic Syndrome, the evidence is preliminary (rated 2/5), and further research is needed before it can be recommended as a standard treatment.

More about Vanadyl sulfate
More about Metabolic Syndrome

Other ingredients used for Metabolic Syndrome

Other health conditions supported by Vanadyl sulfate

Products containing Vanadyl sulfate

Vitabase Active Woman's Multi
Thorne Diabenil